Merck Exec Says Co Focused on Small Molecule Orals, Versus Injectables in the Cardiometabolic Drug Market - Goldman Sachs Conf
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.